Frequent HIN-1 Promoter Methylation and Lack of Expression in Multiple Human Tumor Types
Ian E. Krop(Yale Cancer Center), Kornélia Polyák(Dana-Farber Cancer Institute), William G. Richards(Brigham and Women's Hospital), Nickolas Papadopoulos(Johns Hopkins University), Junya Fukuoka(University of Nagasaki), Matthew Meyerson(Broad Institute), William R. Sellers(Broad Institute), Audrey Player(National Cancer Institute), Massimo Loda(Cornell University), Renée L. Wright(Dana-Farber Cancer Institute), Ana Tablante(Dana-Farber Cancer Institute), Michele Taylor-Parker(Harvard University), Surinder K. Batra(Nebraska Medical Center), Judy Shim(Dana-Farber Cancer Institute), Jin Jen(National Institutes of Health), David J. Sugarbaker(Unknown), Ralph H. Hruban(Johns Hopkins University), Thomas A. Stamey(Stanford Medicine), Jaana Lahti‐Domenici(Dana-Farber Cancer Institute)
Cited by 55
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
Cancer Genome Landscapes
|Science|2013|8k